CTNM short interest
Contineum Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 3,067,588 |
|---|---|
| Change vs prior report | 623,880 (+25.5%) |
| Change over six months | +10.4% |
| Days to cover | 3.62 (sector: 3.78) |
| Average daily volume | 847,470 |
| Rank in Healthcare | #569 of 922 by days to cover |
CTNM short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 3,067,588 | +25.5% | 3.62 | 847,470 |
| 2026-09-15 | 2,443,708 | +4.4% | 6.94 | 352,131 |
| 2026-08-31 | 2,340,890 | +0.2% | 4.02 | 582,694 |
| 2026-08-14 | 2,336,664 | -17.2% | 4.46 | 524,037 |
| 2026-07-31 | 2,822,177 | +15.5% | 13.53 | 208,549 |
| 2026-07-15 | 2,443,643 | +14.3% | 7.32 | 333,697 |
| 2026-06-30 | 2,137,692 | +29.2% | 2.97 | 720,371 |
| 2026-06-15 | 1,654,976 | +15.6% | 7.60 | 217,886 |
| 2026-05-29 | 1,431,603 | +1.0% | 9.36 | 152,955 |
| 2026-05-15 | 1,417,410 | -11.7% | 6.74 | 210,249 |
| 2026-04-30 | 1,605,258 | -48.2% | 6.71 | 239,404 |
| 2026-04-15 | 3,098,809 | +11.5% | 12.73 | 243,430 |
| 2026-03-31 | 2,779,583 | +5.2% | 5.96 | 466,449 |
| 2026-03-13 | 2,642,285 | +3.7% | 9.99 | 264,511 |
| 2026-02-27 | 2,548,283 | -1.3% | 15.86 | 160,655 |
| 2026-02-13 | 2,581,831 | -0.6% | 11.19 | 230,733 |
| 2026-01-30 | 2,596,536 | +0.3% | 9.77 | 265,797 |
| 2026-01-15 | 2,588,693 | +5.5% | 9.58 | 270,282 |
| 2025-12-31 | 2,453,309 | +44.0% | 10.67 | 229,839 |
| 2025-12-15 | 1,703,211 | +62.4% | 6.39 | 266,457 |
| 2025-11-28 | 1,048,944 | -11.9% | 4.17 | 251,322 |
| 2025-11-14 | 1,190,737 | -2.7% | 9.69 | 122,912 |
| 2025-10-31 | 1,224,141 | +6.6% | 13.90 | 88,079 |
| 2025-10-15 | 1,148,688 | -4.3% | 12.17 | 94,381 |
| 2025-09-30 | 1,200,515 | +36.4% | 4.77 | 251,472 |
import finzdata as yf
yf.Ticker("CTNM").short_interest # every report since 2017
yf.Client().short_interest(["CTNM"], start="2018-01-01")Healthcare short interest · CTNM price history · Who owns CTNM · All short interest